{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:36Z","timestamp":1792790556185,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-008627"],"award-info":[{"award-number":["INV-008627"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Murdoch Children\u2019s Research Institute is supported by the Victorian Government\u2019s Operational Infrastructure Support Program","id":[{"id":"https:\/\/ror.org\/048fyec77","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51413-7","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T21:01:53Z","timestamp":1723582913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Memory B cell responses induced by pneumococcal conjugate vaccine schedules with fewer doses: analysis of a randomised-controlled trial in Viet Nam"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-1376","authenticated-orcid":false,"given":"Darren Suryawijaya","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5056-7285","authenticated-orcid":false,"given":"Thanh V.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Temple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0282-5837","authenticated-orcid":false,"given":"Zheng Quan","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0599-8645","authenticated-orcid":false,"given":"Cattram Duong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kien","family":"Vientrung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Van Anh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo","family":"Thi Trang Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Bright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau Phuc","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Ann","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Bun","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuong","family":"Vu Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-6285","authenticated-orcid":false,"given":"Paul Vincent","family":"Licciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"51413_CR1","unstructured":"Global Burden of Disease Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 18, 1191\u20131210 (2018)."},{"key":"51413_CR2","unstructured":"International Vaccine Access Centre. VIEW-hub (John Hopkins Bloomberg School of Public Health, 2024). Available from: www.view-hub.org."},{"key":"51413_CR3","unstructured":"International Vaccine Access Centre. Pneumonia and diarrhea progress report 2023 (John Hopkins Bloomberg School of Public Health; 2023)."},{"key":"51413_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3201\/eid2801.210734","volume":"28","author":"G Hanquet","year":"2022","unstructured":"Hanquet, G. et al. Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe. Emerg. Infect. Dis. 28, 137\u2013138 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"51413_CR5","unstructured":"World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper - February 2019. World Health Org. Weekly Epidemiological Record 8, 85\u2013104 (2019)."},{"key":"51413_CR6","doi-asserted-by":"publisher","first-page":"e1001839","DOI":"10.1371\/journal.pmed.1001839","volume":"12","author":"S Flasche","year":"2015","unstructured":"Flasche, S. et al. The potential for reducing the number of pneumococcal conjugate vaccine doses while sustaining herd immunity in high-income countries. PLoS Med. 12, e1001839 (2015).","journal-title":"PLoS Med."},{"key":"51413_CR7","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S1473-3099(20)30492-8","volume":"21","author":"SN Ladhani","year":"2021","unstructured":"Ladhani, S. N., Andrews, N. & Ramsay, M. E. Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK. Lancet Infect. Dis. 21, e93\u2013e102 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"51413_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(23)00706-5","volume":"24","author":"M Bertran","year":"2024","unstructured":"Bertran, M. et al. Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study. Lancet Infect. Dis. 24, 546\u2013556 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"51413_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1473-3099(23)00061-0","volume":"23","author":"B Temple","year":"2023","unstructured":"Temple, B. et al. Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet Nam: a parallel, single-blind, randomised controlled trial. Lancet Infect. Dis. 23, 933\u2013944 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"51413_CR10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S1473-3099(20)30775-1","volume":"21","author":"PV Licciardi","year":"2021","unstructured":"Licciardi, P. V. et al. Immunogenicity of alternative ten-valent pneumococcal conjugate vaccine schedules in infants in Ho Chi Minh City, Vietnam: results from a single-blind, parallel-group, open-label, randomised, controlled trial. Lancet Infect. Dis. 21, 1415\u20131428 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"51413_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/vaccines7010013","volume":"7","author":"I Papadatou","year":"2019","unstructured":"Papadatou, I., Tzovara, I. & Licciardi, P. V. The role of serotype-specific immunological memory in pneumococcal vaccination: current knowledge and future prospects. Vaccines 7, 13 (2019).","journal-title":"Vaccines"},{"key":"51413_CR12","doi-asserted-by":"publisher","first-page":"e1006665","DOI":"10.1371\/journal.ppat.1006665","volume":"13","author":"SP Jochems","year":"2017","unstructured":"Jochems, S. P., Weiser, J. N., Malley, R. & Ferreira, D. M. The immunological mechanisms that control pneumococcal carriage. PLoS Pathog. 13, e1006665 (2017).","journal-title":"PLoS Pathog."},{"key":"51413_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1164\/rccm.201512-2467OC","volume":"194","author":"SH Pennington","year":"2016","unstructured":"Pennington, S. H. et al. Polysaccharide-specific memory B cells predict protection against experimental human pneumococcal carriage. Am. J. Respir. Crit. Care Med. 194, 1523\u20131531 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"51413_CR14","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1080\/21645515.2020.1753438","volume":"16","author":"TJ Chapman","year":"2020","unstructured":"Chapman, T. J., Pichichero, M. E. & Kaur, R. Comparison of pneumococcal conjugate vaccine (PCV-13) cellular immune responses after primary and booster doses of vaccine. Hum. Vaccin Immunother. 16, 3201\u20133207 (2020).","journal-title":"Hum. Vaccin Immunother."},{"key":"51413_CR15","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1097\/INF.0000000000001497","volume":"36","author":"J Truck","year":"2017","unstructured":"Truck, J. et al. Divergent memory B cell responses in a mixed infant pneumococcal conjugate vaccine schedule. Pediatr. Infect. Dis. J. 36, e130\u2013e135 (2017).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"51413_CR16","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.vaccine.2017.03.079","volume":"35","author":"J Truck","year":"2017","unstructured":"Truck, J. et al. Memory B cell response to a PCV-13 booster in 3.5 year old children primed with either PCV-7 or PCV-13. Vaccine 35, 2701\u20132708 (2017).","journal-title":"Vaccine"},{"key":"51413_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/cei.12637","volume":"181","author":"DM Muema","year":"2015","unstructured":"Muema, D. M. et al. 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers. Clin. Exp. Immunol. 181, 297\u2013305 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"51413_CR18","first-page":"100273","volume":"16","author":"RA Higgins","year":"2021","unstructured":"Higgins, R. A. et al. Immunogenicity and impact on nasopharyngeal carriage of a single dose of PCV10 given to Vietnamese children at 18 months of age. Lancet Reg. Health West Pac. 16, 100273 (2021).","journal-title":"Lancet Reg. Health West Pac."},{"key":"51413_CR19","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1016\/j.vaccine.2017.09.005","volume":"35","author":"C Alicino","year":"2017","unstructured":"Alicino, C. et al. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: a systematic review and meta-analysis. Vaccine 35, 5776\u20135785 (2017).","journal-title":"Vaccine"},{"key":"51413_CR20","doi-asserted-by":"publisher","first-page":"e0212295","DOI":"10.1371\/journal.pone.0212295","volume":"14","author":"JS Ngocho","year":"2019","unstructured":"Ngocho, J. S. et al. Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: a systematic review. PLoS One 14, e0212295 (2019).","journal-title":"PLoS One"},{"key":"51413_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1914-3","volume":"16","author":"BA Kwambana-Adams","year":"2016","unstructured":"Kwambana-Adams, B. A. et al. An outbreak of pneumococcal meningitis among older children (\u22655 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana. BMC Infect. Dis. 16, 575 (2016).","journal-title":"BMC Infect. Dis."},{"key":"51413_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1450-2","volume":"17","author":"J Lourenco","year":"2019","unstructured":"Lourenco, J. et al. Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study. BMC Med. 17, 219 (2019).","journal-title":"BMC Med."},{"key":"51413_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","volume":"14","author":"NJ Andrews","year":"2014","unstructured":"Andrews, N. J. et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect. Dis. 14, 839\u2013846 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"51413_CR24","doi-asserted-by":"publisher","first-page":"e52464","DOI":"10.1371\/journal.pone.0052464","volume":"7","author":"JE Mueller","year":"2012","unstructured":"Mueller, J. E. et al. Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults. PLoS One 7, e52464 (2012).","journal-title":"PLoS One"},{"key":"51413_CR25","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1172\/JCI128865","volume":"129","author":"SP Jochems","year":"2019","unstructured":"Jochems, S. P. et al. Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization. J. Clin. Invest. 129, 4523\u20134538 (2019).","journal-title":"J. Clin. Invest."},{"key":"51413_CR26","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S1473-3099(22)00438-8","volume":"22","author":"TD Swarthout","year":"2022","unstructured":"Swarthout, T. D. et al. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study. Lancet Infect. Dis. 22, 1737\u20131747 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"51413_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","volume":"32","author":"SM Davis","year":"2013","unstructured":"Davis, S. M., Deloria-Knoll, M., Kassa, H. T. & O\u2019Brien, K. L. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 32, 133\u2013145 (2013).","journal-title":"Vaccine"},{"key":"51413_CR28","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.15585\/mmwr.mm6945a7","volume":"69","author":"AN Chard","year":"2020","unstructured":"Chard, A. N., Gacic-Dobo, M., Diallo, M. S., Sodha, S. V. & Wallace, A. S. Routine vaccination coverage - worldwide, 2019. Morb. Mortal. Wkly Rep. 69, 1706\u20131710 (2020).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"51413_CR29","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","volume":"6","author":"B Wahl","year":"2018","unstructured":"Wahl, B. et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob. Health 6, e744\u2013e757 (2018).","journal-title":"Lancet Glob. Health"},{"key":"51413_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","volume":"286","author":"S Crotty","year":"2004","unstructured":"Crotty, S., Aulbert, R. D., Glidewell, J. & Ahmed, R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286, 111\u2013122 (2004).","journal-title":"J. Immunol. Methods"},{"key":"51413_CR31","doi-asserted-by":"publisher","first-page":"821729","DOI":"10.3389\/fimmu.2021.821729","volume":"12","author":"M Broketa","year":"2021","unstructured":"Broketa, M. & Bruhns, P. Single-cell technologies for the study of antibody-secreting cells. Front. Immunol. 12, 821729 (2021).","journal-title":"Front. Immunol."},{"key":"51413_CR32","doi-asserted-by":"publisher","first-page":"e056505","DOI":"10.1136\/bmjopen-2021-056505","volume":"11","author":"B Temple","year":"2021","unstructured":"Temple, B. et al. Simplified 0+1 and 1+1 pneumococcal vaccine schedules in Ho Chi Minh City, Vietnam: protocol for a randomised controlled trial. BMJ Open 11, e056505 (2021).","journal-title":"BMJ Open"},{"key":"51413_CR33","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.jaci.2015.12.1303","volume":"137","author":"PV Licciardi","year":"2016","unstructured":"Licciardi, P. V. et al. No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine. J. Allergy Clin. Immunol. 137, 1772\u20131779 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"51413_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.vaccine.2009.11.011","volume":"28","author":"A Balloch","year":"2010","unstructured":"Balloch, A., Licciardi, P. V., Leach, A., Nurkka, A. & Tang, M. L. Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance. Vaccine 28, 1333\u20131340 (2010).","journal-title":"Vaccine"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51413-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51413-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51413-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T21:03:49Z","timestamp":1723583029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51413-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51413"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51413-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4484612\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors from Australia and Viet Nam received salary support from the Bill & Melinda Gates Foundation grant. C.D.M. is a co-investigator\/biostatistician on a Merck Investigator Studies Program grant funded by M.S.D. on pneumococcal serotype epidemiology in children with empyema. C.D.N. and K.M. are co-investigators on a clinical research collaboration on a separate study funded by Pfizer examining impacts of PCV vaccination on adults in Mongolia.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6968"}}